About
Linnaeus Therapeutics is a biotech company developing small molecule drugs for cancer treatment, focusing on their lead compound LNS8801, a potent GPER agonist currently in clinical trials.
Explore Linnaeus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.